Items where authors include "Kurzidim, L."
Jump to: Article | Conference abstract
Number of items: 2.
Article
Mainz, J.G., Zagoya, C., Polte, L. et al. (12 more authors) (2023) Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score. Frontiers in Pharmacology, 14. 1207356. ISSN 1663-9812
Conference abstract
Mainz, J.G., Zagoya, C., Polte, L. et al. (12 more authors) (2022) WS02.01 Abdominal symptoms significantly decline after 24 weeks of elexacaftor/tezacaftor/ivacaftor treatment: first results obtained with the cystic fibrosis-specific CFAbd-Score in Germany and the UK. [Conference abstract]
Up a level